Carsten Bach Baunsgaard1, Ulla Vig Nissen2, Anne Katrin Brust3, Angela Frotzler3, Cornelia Ribeill4, Yorck-Bernhard Kalke4, Natacha León5, Belén Gómez5, Kersti Samuelsson6, Wolfram Antepohl6, Ulrika Holmström7, Niklas Marklund7, Thomas Glott8, Arve Opheim8,9, Jesus Benito10, Narda Murillo10, Janneke Nachtegaal11, Willemijn Faber11, Fin Biering-Sørensen2. 1. Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. cb.baunsgaard@gmail.com. 2. Clinic for Spinal Cord Injuries, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark. 3. Swiss Paraplegic Centre (SPC), Nottwil, Switzerland. 4. SCI Centre Orthopaedic Department Ulm University, Ulm, Germany. 5. Fundación Lesionado Medular (FLM), Madrid, Spain. 6. Department of Rehabilitation Medicine and Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 7. Spinal Cord Rehabilitation Unit, Uppsala University Hospital, Uppsala, Sweden. 8. Sunnaas Rehabilitation Hospital, Nesoddtangen, Norway. 9. Rehabilitation Medicine, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 10. Institute Guttmann, Neurorehabilitation Hospital, Barcelona, Spain. 11. Heliomare Rehabilitation Center, Wijk aan Zee, The Netherlands.
Abstract
STUDY DESIGN: Prospective quasi-experimental study, pre- and post-design. OBJECTIVES: Assess safety, feasibility, training characteristics and changes in gait function for persons with spinal cord injury (SCI) using the robotic exoskeletons from Ekso Bionics. SETTING: Nine European rehabilitation centres. METHODS: Robotic exoskeleton gait training, three times weekly over 8 weeks. Time upright, time walking and steps in the device (training characteristics) were recorded longitudinally. Gait and neurological function were measured by 10 Metre Walk Test (10 MWT), Timed Up and Go (TUG), Berg Balance Scale (BBS), Walking Index for Spinal Cord Injury (WISCI) II and Lower Extremity Motor Score (LEMS). RESULTS: Fifty-two participants completed the training protocol. Median age: 35.8 years (IQR 27.5-52.5), men/women: N = 36/16, neurological level of injury: C1-L2 and severity: AIS A-D (American Spinal Injury Association Impairment Scale). Time since injury (TSI) < 1 year, N = 25; > 1 year, N = 27. No serious adverse events occurred. Three participants dropped out following ankle swelling (overuse injury). Four participants sustained a Category II pressure ulcer at contact points with the device but completed the study and skin normalized. Training characteristics increased significantly for all subgroups. The number of participants with TSI < 1 year and gait function increased from 20 to 56% (P = 0.004) and 10MWT, TUG, BBS and LEMS results improved (P < 0.05). The number of participants with TSI > 1 year and gait function, increased from 41 to 44% and TUG and BBS results improved (P < 0.05). CONCLUSIONS: Exoskeleton training was generally safe and feasible in a heterogeneous sample of persons with SCI. Results indicate potential benefits on gait function and balance.
STUDY DESIGN: Prospective quasi-experimental study, pre- and post-design. OBJECTIVES: Assess safety, feasibility, training characteristics and changes in gait function for persons with spinal cord injury (SCI) using the robotic exoskeletons from Ekso Bionics. SETTING: Nine European rehabilitation centres. METHODS: Robotic exoskeleton gait training, three times weekly over 8 weeks. Time upright, time walking and steps in the device (training characteristics) were recorded longitudinally. Gait and neurological function were measured by 10 Metre Walk Test (10 MWT), Timed Up and Go (TUG), Berg Balance Scale (BBS), Walking Index for Spinal Cord Injury (WISCI) II and Lower Extremity Motor Score (LEMS). RESULTS: Fifty-two participants completed the training protocol. Median age: 35.8 years (IQR 27.5-52.5), men/women: N = 36/16, neurological level of injury: C1-L2 and severity: AIS A-D (American Spinal Injury Association Impairment Scale). Time since injury (TSI) < 1 year, N = 25; > 1 year, N = 27. No serious adverse events occurred. Three participants dropped out following ankle swelling (overuse injury). Four participants sustained a Category II pressure ulcer at contact points with the device but completed the study and skin normalized. Training characteristics increased significantly for all subgroups. The number of participants with TSI < 1 year and gait function increased from 20 to 56% (P = 0.004) and 10MWT, TUG, BBS and LEMS results improved (P < 0.05). The number of participants with TSI > 1 year and gait function, increased from 41 to 44% and TUG and BBS results improved (P < 0.05). CONCLUSIONS: Exoskeleton training was generally safe and feasible in a heterogeneous sample of persons with SCI. Results indicate potential benefits on gait function and balance.
Authors: Gabi Zeilig; Harold Weingarden; Manuel Zwecker; Israel Dudkiewicz; Ayala Bloch; Alberto Esquenazi Journal: J Spinal Cord Med Date: 2012-02-07 Impact factor: 1.985
Authors: Steven C Kirshblum; Michael M Priebe; Chester H Ho; William M Scelza; Anthony E Chiodo; Lisa-Ann Wuermser Journal: Arch Phys Med Rehabil Date: 2007-03 Impact factor: 3.966
Authors: Mirko Aach; Oliver Cruciger; Matthias Sczesny-Kaiser; Oliver Höffken; Renate Ch Meindl; Martin Tegenthoff; Peter Schwenkreis; Yoshiyuki Sankai; Thomas A Schildhauer Journal: Spine J Date: 2014-04-04 Impact factor: 4.166
Authors: X Wu; J Liu; L G Tanadini; D P Lammertse; A R Blight; John L K Kramer; G Scivoletto; L Jones; S Kirshblum; R Abel; J Fawcett; E Field-Fote; J Guest; B Levinson; D Maier; K Tansey; N Weidner; W G Tetzlaff; T Hothorn; A Curt; J D Steeves Journal: Spinal Cord Date: 2014-12-16 Impact factor: 2.772
Authors: Andrew D Delgado; Miguel X Escalon; Thomas N Bryce; William Weinrauch; Stephanie J Suarez; Allan J Kozlowski Journal: J Spinal Cord Med Date: 2019-10-11 Impact factor: 1.985
Authors: James Faulkner; Louis Martinelli; Kirsty Cook; Lee Stoner; Helen Ryan-Stewart; Eloise Paine; Helen Hobbs; Danielle Lambrick Journal: J Spinal Cord Med Date: 2019-09-16 Impact factor: 1.985
Authors: Chung-Ying Tsai; Pierre K Asselin; Eunkyoung Hong; Steven Knezevic; Stephen D Kornfeld; Noam Y Harel; Ann M Spungen Journal: Spinal Cord Ser Cases Date: 2021-03-12